Sort   by:  
 Page size 
UnknownBerberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study).
Not available
S-EPMC9974661 | biostudies-literature
UnknownAssociation of Small Intestinal Bacterial Overgrowth With Heart Failure and Its Prediction for Short-Term Outcomes.
Not available
S-EPMC8174348 | biostudies-literature
UnknownMucosa-Associated Microbial Profile Is Altered in Small Intestinal Bacterial Overgrowth.
Not available
S-EPMC8372370 | biostudies-literature
UnknownComparative efficacy of diverse therapeutic regimens for small intestinal bacterial overgrowth: a systematic network meta-analysis.
Not available
S-EPMC12699006 | biostudies-literature
UnknownPatients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity.
Not available
S-EPMC9509105 | biostudies-literature
UnknownPrediction and management of strangulated bowel obstruction: a multi-dimensional model analysis.
Not available
S-EPMC9219133 | biostudies-literature
UnknownAn easily acquirable predictive model for strangulated bowel obstruction: the BAR-N.
Not available
S-EPMC12374450 | biostudies-literature
Sort   by:  
 Page size